Cargando…

2-(5,6-Dihydro­benzimidazo[1,2-c]quinazolin-6-yl)-5-methyl­phenol

In the title compound, C(21)H(17)N(3)O, the imidazole ring is essentially planar, with a maximum deviation of 0.009 (1) Å. The mol­ecule is disordered over two sites corresponding to a rotation of approximately 180° with a refined occupancy ratio of 0.9180 (14):0.0820 (14). The central pyrim­idine r...

Descripción completa

Detalles Bibliográficos
Autores principales: Eltayeb, Naser Eltaher, Teoh, Siang Guan, Hemamalini, Madhukar, Fun, Hoong-Kun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Union of Crystallography 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3200579/
https://www.ncbi.nlm.nih.gov/pubmed/22058979
http://dx.doi.org/10.1107/S1600536811032673
Descripción
Sumario:In the title compound, C(21)H(17)N(3)O, the imidazole ring is essentially planar, with a maximum deviation of 0.009 (1) Å. The mol­ecule is disordered over two sites corresponding to a rotation of approximately 180° with a refined occupancy ratio of 0.9180 (14):0.0820 (14). The central pyrim­idine ring makes dihedral angles of 5.02 (5), 3.97 (5) and 6.28 (5)°, respectively, with the planes of the imidazole and the terminal phenyl rings for the major component; the values for the minor component are 5.8 (7), 5.0 (6) and 8.5 (6)°, respectively. Part of the observed planarity is accounted for in terms of an intra­molecular N—H⋯O hydrogen bond. In the crystal, mol­ecules of the major component are connected by O—H⋯N hydrogen bonds, forming supra­molecular chains along the c axis.